Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 21;12(1):39.
doi: 10.1186/s13756-023-01240-0.

Incremental costs of hospital-acquired infections in COVID-19 patients in an adult intensive care unit of a tertiary hospital from a low-resource setting

Aleksa Despotović  1 , Nataša Milić  2   3 , Anđa Cirković  2 , Branko Milošević  4   5 , Snežana Jovanović  6 , Vesna Mioljević  7 , Vesna Obradović  5 , Gordana Kovačević  5 , Goran Stevanović  4   5
Affiliations

Incremental costs of hospital-acquired infections in COVID-19 patients in an adult intensive care unit of a tertiary hospital from a low-resource setting

Aleksa Despotović et al. Antimicrob Resist Infect Control. .

Abstract

Background: Hospital-acquired infections (HAIs) are a global public health problem and put patients at risk of complications, including death. HAIs increase treatment costs, but their financial impact on Serbia's healthcare system is unknown. Our goal was to assess incremental costs of HAIs in a tertiary care adult intensive care unit (ICU) that managed COVID-19 patients.

Methods: A retrospective study from March 6th to December 31st, 2020 included patients with microbiologically confirmed COVID-19 (positive rapid antigen test or real-time polymerase chain reaction) treated in the ICU of the Teaching Hospital for Infectious and Tropical Diseases, University Clinical Centre of Serbia. Demographic and HAI-specific data acquired in our ICU were collected, including total and stratified medical costs (services, materials, laboratory testing, medicines, occupancy costs). Median total and stratified costs were compared in relation to HAI acquisition. Linear regression modelling was used to assess incremental costs of HAIs, adjusted for age, biological sex, prior hospitalisation, Charlson Comorbidity Index (CCI), and Glasgow Coma Scale (GCS) on admission. Outcome variables were length of stay (LOS) in days and mortality.

Results: During the study period, 299 patients were treated for COVID-19, of which 214 were included. HAIs were diagnosed in 56 (26.2%) patients. Acinetobacter spp. was the main pathogen in respiratory (38, 45.8%) and bloodstream infections (35, 42.2%), the two main HAI types. Median total costs were significantly greater in patients with HAIs (€1650.4 vs. €4203.2, p < 0.001). Longer LOS (10.0 vs. 18.5 days, p < 0.001) and higher ICU mortality (51.3% vs. 89.3%, p < 0.001) were seen if HAIs were acquired. Patients with ≥ 2 HAIs had the highest median total costs compared to those without HAIs or with a single HAI (€1650.4 vs. €3343.4 vs. €7336.9, p < 0.001). Incremental costs in patients with 1 and ≥ 2 HAIs were €1837.8 (95% CI 1257.8-2417.7, p < 0.001) and €5142.5 (95% CI 4262.3-6022.7, p < 0.001), respectively.

Conclusions: This is the first economic evaluation of HAIs in Serbia, showing significant additional costs to our healthcare system. HAIs prolong LOS and influence ICU mortality rates. Larger economic assessments are needed to enhance infection control practices.

Keywords: COVID-19; Economic evaluation; Hospital-acquired infections; Intensive care unit; Medical costs; Serbia.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
CONSORT Flow Diagram
Fig. 2
Fig. 2
Distribution of total treatment costs in patients with and without HAIs
Fig. 3
Fig. 3
Distribution of total treatment costs in patients with no HAIs, 1 HAI, and ≥ 2 HAIs.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Suetens C, Latour K, Kärki T, Ricchizzi E, Kinross P, Moro ML et al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017.Euro Surveill. 2018;23(46). - PMC - PubMed
    1. Kärki T, Plachouras D, Cassini A, Suetens C. Burden of healthcare-associated infections in european acute care hospitals. Wien Med Wochenscher. 2019;169(1):3–5. doi: 10.1007/s10354-018-0679-2. - DOI - PubMed
    1. Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66. doi: 10.1016/S1473-3099(18)30605-4. - DOI - PMC - PubMed
    1. Lydeamore MJ, Mitchell BG, Bucknall T, Cheng AC, Russo PL, Stewardson AJ. Burden of five healthcare associated infections in Australia. Antimicrob Resist Infect Control. 2022;11(1):69. doi: 10.1186/s13756-022-01109-8. - DOI - PMC - PubMed
    1. Schreiber PW, Sax H, Wolfensberger A, Clack L, Kuster SP. The preventable proportion of healthcare-associated infections 2005–2016: systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2018;39(11):1277–95. doi: 10.1017/ice.2018.183. - DOI - PubMed